In our study, we demonstrated that targeting P4HA1 significantly inhibits CRC growth, metastasis, and TAM infiltration, primarily through the modulation of the P4HA2‐PI3K‐AKT signaling pathway. The gene discussed is P4HA2; the disease is colorectal carcinoma.